+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Suboxone"

Addictions Therapeutics Market Report 2025 - Product Thumbnail Image

Addictions Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Opioid Use Disorder Market Report and Forecast 2024-2032 - Product Thumbnail Image

Opioid Use Disorder Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 168 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Suboxone is a brand name for a combination of buprenorphine and naloxone, two medications used to treat opioid addiction. It is a partial opioid agonist, meaning it binds to opioid receptors in the brain, but does not produce the same level of euphoria as full opioid agonists. Suboxone is used to reduce cravings and withdrawal symptoms associated with opioid addiction, and to help people maintain abstinence from opioids. It is available in both tablet and film form, and is typically taken once or twice daily. Suboxone is a popular treatment option for opioid addiction, as it is effective and has fewer side effects than other medications. It is also relatively easy to access, as it is available through both prescription and over-the-counter channels. Companies in the Suboxone market include Reckitt Benckiser, which manufactures the brand name Suboxone, as well as generic versions of the drug. Other companies include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more